These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 30372589

  • 1. Calcium channel blockers are associated with improved survival and lower cardiovascular mortality in patients with renovascular disease.
    Deshmukh H, Barker E, Anbarasan T, Levin D, Bell S, Witham MD, George J.
    Cardiovasc Ther; 2018 Dec; 36(6):e12474. PubMed ID: 30372589
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug therapy of renovascular hypertension.
    Rosenthal T.
    Drugs; 1993 Jun; 45(6):895-909. PubMed ID: 7691497
    [Abstract] [Full Text] [Related]

  • 5. Hypertension, antihypertensive agents and outcomes following renal transplantation.
    Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RS, Geddes CC, Jardine AG.
    Clin Transplant; 2005 Apr; 19(2):181-92. PubMed ID: 15740553
    [Abstract] [Full Text] [Related]

  • 6. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G, Koylan N, Nalbantgil I, Caglar N, Quarti-Trevano F, Makel W, Grassi G, Fici F.
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.
    Cochrane Database Syst Rev; 2014 Feb 01; 2014(2):CD008117. PubMed ID: 24488616
    [Abstract] [Full Text] [Related]

  • 8. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May 01; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

  • 9. Renal artery stenosis: a disease worth pursuing.
    Parker SC, Hannah A, Brooks M, Louis WJ, O'Callaghan CJ.
    Med J Aust; 2001 Aug 06; 175(3):149-53. PubMed ID: 11548082
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.
    Evid Based Child Health; 2014 Sep 06; 9(3):498-580. PubMed ID: 25236305
    [Abstract] [Full Text] [Related]

  • 11. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ, Li Y, Liu SM, Sun XG, Li M, Hao Y, Cui LQ, Wang AH.
    Ren Fail; 2016 Jul 06; 38(6):849-56. PubMed ID: 27055479
    [Abstract] [Full Text] [Related]

  • 12. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS.
    Evid Based Child Health; 2014 Sep 06; 9(3):581-3. PubMed ID: 25236306
    [Abstract] [Full Text] [Related]

  • 13. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH, Smith DJ, McCallum L, Muir S, Touyz RM, Dominiczak AF, Padmanabhan S.
    Hypertension; 2016 Nov 06; 68(5):1132-1138. PubMed ID: 27733585
    [Abstract] [Full Text] [Related]

  • 14. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL.
    J Am Pharm Assoc (2003); 2010 Nov 06; 50(5):e116-25. PubMed ID: 20833609
    [Abstract] [Full Text] [Related]

  • 15. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
    Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, Penso L, Herlemont P, Sbidian E, Weill A, Dray-Spira R, Zureik M.
    Hypertension; 2021 Mar 03; 77(3):833-842. PubMed ID: 33423528
    [Abstract] [Full Text] [Related]

  • 16. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR, Dworkin LD, Henrich W, Greco BA, Steffes M, Tobe S, Shapiro JI, Jamerson K, Lyass A, Pencina K, Massaro JM, D'Agostino RB, Cutlip DE, Murphy TP, Cooper CJ.
    Clin J Am Soc Nephrol; 2016 Jul 07; 11(7):1180-1188. PubMed ID: 27225988
    [Abstract] [Full Text] [Related]

  • 17. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
    Mousa AY, Campbell JE, Stone PA, Broce M, Bates MC, AbuRahma AF.
    J Vasc Surg; 2012 Feb 07; 55(2):421-7. PubMed ID: 22112553
    [Abstract] [Full Text] [Related]

  • 18. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
    Haroon S, Subramanian A, Cooper J, Anand A, Gokhale K, Byne N, Dhalla S, Acosta-Mena D, Taverner T, Okoth K, Wang J, Chandan JS, Sainsbury C, Zemedikun DT, Thomas GN, Parekh D, Marshall T, Sapey E, Adderley NJ, Nirantharakumar K.
    BMC Infect Dis; 2021 Mar 15; 21(1):262. PubMed ID: 33722197
    [Abstract] [Full Text] [Related]

  • 19. [Hypertension therapy in patients with renal artery stenosis].
    Vogt B, Maillard M, Burnier M.
    Ther Umsch; 2012 May 15; 69(5):279-81. PubMed ID: 22547359
    [Abstract] [Full Text] [Related]

  • 20. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.
    JAMA; 2004 Dec 15; 292(23):2849-59. PubMed ID: 15598916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.